MNKD Q3 2023 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$51M+56.1% YoY

Gross Profit

$37M72.2% margin

Operating Income

$5M9.9% margin

Net Income

$2M3.4% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

-$3M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$320M

Total Liabilities

$572M

Stockholders' Equity

-$252M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$33M	+56.1%
Gross Profit	$37M	$15M	+140.8%
Operating Income	$5M	-$10M	+153.0%
Net Income	$2M	-$14M	+111.9%

Revenue Segments

License and Service

$10M100%